Dr Reddys
-
{
- All
- News
- Videos
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Cyber Fraud Targeting Drugmaker Dr Reddy's Busted, Rs 2.16 Crore Recovered
Group Pharmaceuticals was due to receive a payment of Rs 2.16 crore from Dr. Reddy's Laboratories. However, hackers gained access to their emails and diverted funds.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
-
Why Top Drugmaker Is Surprisingly Downbeat About Covid Pill, Sputnik Shot
For a drugmaker licensed to produce Merck & Co.'s promising Covid-19 pill and sell Russia's Sputnik V shot, Dr Reddy's Laboratories Ltd. is surprisingly mellow about the rewards it expects from these medical breakthroughs.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
India Will Accept 1-Dose Sputnik Light Trial Data From Russia: Dr Reddy's
A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for
-
Dr Reddy's Announces Commercial Launch Of Covid Drug 2-DG, Caps Price
Dr Reddy's Laboratories today announced the commercial launch of 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, adding that the drug will be available across hospitals in metros and Tier 1 cities in the initial weeks.
-
Local Production May Bring Down Sputnik V Vaccine Prices: Dr Reddy's
The pricing of the Sputnik V COVID-19 vaccine, currently capped at Rs 995 per dose, is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy's Laboratories.
-
When, Where And How Much - Your Questions About Sputnik V Answered
The first doses of Russia's Sputnik V COVID-19 vaccine were given out in India on Friday in a soft launch that is expected to be scaled up in the coming days.
-
Sputnik V (Imported) To Cost Rs 995 Per Shot, First Dose Administered
An imported dose of Russia's Sputnik V vaccine against coronavirus will cost Rs. 995.40 in India, Dr Reddy's Laboratories, which is manufacturing the vaccine in India, said today.
-
Anti-Covid Drug Developed By DRDO Cleared For Emergency Use
A drug to treat coronavirus patients, developed by the DRDO, has been approved for emergency use by the country's top drugs controller as India battles the second wave of the pandemic that is killing thousands every day.
-
Sputnik V Vaccine's India Maker Clarifies Day After Announcing Price
A day after announcing that Russia's Sputnik V vaccine could be sold at $10 (around Rs 750) a dose in India, its manufacturer Dr Reddy's Labs clarified that discussions on the price are still on and there is no final decision yet.
-
Sputnik V Shot To Cost Rs 750, To Arrive By May-June: Dr Reddy's To NDTV
Russia's Sputnik V Covid vaccine will be sold at $10 (around Rs 750) a dose in India, its manufacturer Dr Reddy's Labs has told NDTV.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Cyber Fraud Targeting Drugmaker Dr Reddy's Busted, Rs 2.16 Crore Recovered
Group Pharmaceuticals was due to receive a payment of Rs 2.16 crore from Dr. Reddy's Laboratories. However, hackers gained access to their emails and diverted funds.
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
Trying To Bring Vaccine For 12-18 Age Group To India: Dr Reddy's
Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.
-
Why Top Drugmaker Is Surprisingly Downbeat About Covid Pill, Sputnik Shot
For a drugmaker licensed to produce Merck & Co.'s promising Covid-19 pill and sell Russia's Sputnik V shot, Dr Reddy's Laboratories Ltd. is surprisingly mellow about the rewards it expects from these medical breakthroughs.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
India Will Accept 1-Dose Sputnik Light Trial Data From Russia: Dr Reddy's
A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for
-
Dr Reddy's Announces Commercial Launch Of Covid Drug 2-DG, Caps Price
Dr Reddy's Laboratories today announced the commercial launch of 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, adding that the drug will be available across hospitals in metros and Tier 1 cities in the initial weeks.
-
Local Production May Bring Down Sputnik V Vaccine Prices: Dr Reddy's
The pricing of the Sputnik V COVID-19 vaccine, currently capped at Rs 995 per dose, is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy's Laboratories.
-
When, Where And How Much - Your Questions About Sputnik V Answered
The first doses of Russia's Sputnik V COVID-19 vaccine were given out in India on Friday in a soft launch that is expected to be scaled up in the coming days.
-
Sputnik V (Imported) To Cost Rs 995 Per Shot, First Dose Administered
An imported dose of Russia's Sputnik V vaccine against coronavirus will cost Rs. 995.40 in India, Dr Reddy's Laboratories, which is manufacturing the vaccine in India, said today.
-
Anti-Covid Drug Developed By DRDO Cleared For Emergency Use
A drug to treat coronavirus patients, developed by the DRDO, has been approved for emergency use by the country's top drugs controller as India battles the second wave of the pandemic that is killing thousands every day.
-
Sputnik V Vaccine's India Maker Clarifies Day After Announcing Price
A day after announcing that Russia's Sputnik V vaccine could be sold at $10 (around Rs 750) a dose in India, its manufacturer Dr Reddy's Labs clarified that discussions on the price are still on and there is no final decision yet.
-
Sputnik V Shot To Cost Rs 750, To Arrive By May-June: Dr Reddy's To NDTV
Russia's Sputnik V Covid vaccine will be sold at $10 (around Rs 750) a dose in India, its manufacturer Dr Reddy's Labs has told NDTV.
